Globus Medical (GMED) Tops Q4 EPS by 10c; offers guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Join SI Premium – FREE
Globus Medical (NYSE: GMED) reported Q4 EPS of $0.84, $0.10 better than the analyst estimate of $0.74. Revenue for the quarter came in at $657.29 million versus the consensus estimate of $635.43 million.
GUIDANCE:
Globus Medical sees FY2025 EPS of $3.10-$3.40, versus the consensus of $3.43. Globus Medical sees FY2025 revenue of $2.8-2.9 billion, versus the consensus of $2.672 billion.
For earnings history and earnings-related data on Globus Medical (GMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- Freedom Broker Downgrades RPC Inc. (RES) to Sell
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
